Your browser doesn't support javascript.
loading
Results from the prospective, multicenter AMBULATE-CAP trial: Reduced use of urinary catheters and protamine with hemostasis via the Mid-Bore Venous Vascular Closure System (VASCADE® MVP) following multi-access cardiac ablation procedures.
Al-Ahmad, Amin; Mittal, Suneet; DeLurgio, David; Joseph Gallinghouse, G; Horton, Rodney P; Preminger, Mark W; David Burkhardt, J; Natale, Andrea.
Afiliação
  • Al-Ahmad A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Mittal S; The Valley Health System, Ridgewood, New Jersey, USA.
  • DeLurgio D; Emory Heart and Vascular Center, Emory Saint Joseph's Hospital, Atlanta, Georgia, USA.
  • Joseph Gallinghouse G; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Horton RP; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Preminger MW; The Valley Health System, Ridgewood, New Jersey, USA.
  • David Burkhardt J; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Natale A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
J Cardiovasc Electrophysiol ; 32(2): 191-199, 2021 02.
Article em En | MEDLINE | ID: mdl-33270306

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protaminas / Cateteres Urinários Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protaminas / Cateteres Urinários Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article